Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.579403
Title: Stochastic control methods to individualise drug therapy by incorporating pharmacokinetic, pharmacodynamic and adverse event data
Author: Francis, Ben
Awarding Body: University of Liverpool
Current Institution: University of Liverpool
Date of Award: 2013
Availability of Full Text:
Access from EThOS:
Access from Institution:
Abstract:
There are a number of methods available to clinicians for determining an individualised dosage regimen for a patient. However, often these methods are non-adaptive to the patient’s requirements and do not allow for changing clinical targets throughout the course of therapy. The drug dose algorithm constructed in this thesis, using stochastic control methods, harnesses information on the variability of the patient’s response to the drug thus ensuring the algorithm is adapting to the needs of the patient. Novel research is undertaken to include process noise in the Pharmacokinetic/Pharmacodynamic (PK/PD) response prediction to better simulate the patient response to the dose by allowing values sampled from the individual PK/PD parameter distributions to vary over time. The Kalman filter is then adapted to use these predictions alongside measurements, feeding information back into the algorithm in order to better ascertain the current PK/PD response of the patient. From this a dosage regimen is estimated to induce desired future PK/PD response via an appropriately formulated cost function. Further novel work explores different formulations of this cost function by considering probabilities from a Markov model. In applied examples, previous methodology is adapted to allow control of patients that have missing covariate information to be appropriately dosed in warfarin therapy. Then using the introduced methodology in the thesis, the drug dose algorithm is shown to be adaptive to patient needs for imatinib and simvastatin therapy. The differences, between standard dosing and estimated dosage regimens using the methodologies developed, are wide ranging as some patients require no dose alterations whereas other required a substantial change in dosing to meet the PK/PD targets. The outdated paradigm of ‘one size fits all’ dosing is subject to debate and the research in this thesis adds to the evidence and also provides an algorithm for a better approach to the challenge of individualising drug therapy to treat the patient more effectively. The drug dose algorithm developed is applicable to many different drug therapy scenarios due to the enhancements made to the formulation of the cost functions. With this in mind, application of the drug dose algorithm in a wide range of clinical dosing decisions is possible.
Supervisor: Lane, Steven; Jorgensen, Andrea Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.579403  DOI: Not available
Share: